TSPY1 and hepatocellular carcinoma: To explore the potential pro-oncogenic actions of an aberrantly expressed TSPY in hepatocarcinogenesis, we had used the well-established hydrodynamic tail vein injection strategy to express a human TSPY transgene in an oncogene-induced mouse model of HCC [29, 37].